Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on August 6, 2019. The filing serves to announce the Company's financial performance for the second fiscal quarter and the six months ended June 30, 2019. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document. The filing explicitly states that the detailed financial information is located in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only references the issuance of a press release containing the results of operations and financial condition.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It notes that the information in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act nor incorporated by reference into other filings, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the correct registrant name is MRI Interventions, Inc. (Ticker: MRIC), as the request metadata incorrectly listed "Clearpoint Neuro, Inc."
- Locate and review Exhibit 99.1 (Press Release dated August 6, 2019) to obtain actual revenue, net loss, and cash flow figures.
- Confirm the specific trading exchange is NYSE American.
- Note that the financial data in the press release is not legally "filed" under Section 18 of the Exchange Act unless specifically referenced in another filing.